PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'International Affairs Division, European Medicines Agency, Amsterdam, EU.\', \'Office of International Programs, Pharmaceutical and Medical Devices Agency , Tokyo, Japan.\', \'European Office, Office of International Programs, Food and Drug Administration , Silver Spring, MD, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/17512433.2020.1821650
?:hasPublicationType
?:journal
  • Expert review of clinical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 32909843
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.833
?:rankingScore_hIndex
  • 29
?:title
  • Remdesivir emergency approvals: a comparison of the U.S., Japanese, and EU systems.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32909843>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32909843>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all